FTXH Stock Overview
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF is an exchange traded fund launched and managed by First Trust Advisors LP.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$26.43 |
52 Week High | US$28.41 |
52 Week Low | US$23.85 |
Beta | 0 |
1 Month Change | -3.93% |
3 Month Change | -2.60% |
1 Year Change | -0.038% |
3 Year Change | 3.20% |
5 Year Change | 25.73% |
Change since IPO | 29.31% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
FTXH | US Capital Markets | US Market | |
---|---|---|---|
7D | 2.3% | -1.8% | -0.7% |
1Y | -0.04% | 31.5% | 22.8% |
Return vs Industry: FTXH underperformed the US Capital Markets industry which returned 29% over the past year.
Return vs Market: FTXH underperformed the US Market which returned 22.3% over the past year.
Price Volatility
FTXH volatility | |
---|---|
FTXH Average Weekly Movement | 1.8% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FTXH has not had significant price volatility in the past 3 months.
Volatility Over Time: FTXH's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | n/a | www.ftportfolios.com/retail/etf/etfsummary.aspx?Ticker=FTXH |
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF is an exchange traded fund launched and managed by First Trust Advisors LP. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, pharmaceuticals sectors.
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF Fundamentals Summary
FTXH fundamental statistics | |
---|---|
Market cap | US$19.82m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs FTXH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FTXH income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did FTXH perform over the long term?
See historical performance and comparison